Cardio Diagnostics Holdings, Inc. — Director's Dealing 2024

Apr 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardio Diagnostics Holdings, Inc. (CDIO)
CIK: 0001870144
Period of Report: 2024-03-31

Reporting Person: Burton Paul Frederick (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-31	Common Stock	M	8803	$1.42	Acquired	8803	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-31	Restricted Stock Units	$0	M		Acquired	2024-12-31	Common Stock ()	Direct

Footnotes

F1: Represents the settlement of restricted stock units (RSUs) that vested on March 31, 2024 through the issuance of shares of Common Stock.

F2: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F3: On January 23, 2024, the reporting person was awarded $50,000 in value of RSUs, $12,500 in value of which vested on March 31, 2024. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on June 30, 2024, $12,500 in value on September30, 2024 and $12,500 in value on December 31, 2024, based on the closing price of the Issuers common stock on the applicable vesting date.

F4: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.